Bluejay Diagnostics, Inc. (BJDX): Price and Financial Metrics
BJDX Price/Volume Stats
| Current price | $1.66 | 52-week high | $37.50 |
| Prev. close | $1.61 | 52-week low | $1.46 |
| Day low | $1.61 | Volume | 43,349 |
| Day high | $1.73 | Avg. volume | 918,136 |
| 50-day MA | $1.72 | Dividend yield | N/A |
| 200-day MA | $3.50 | Market Cap | 2.48M |
BJDX Stock Price Chart Interactive Chart >
Bluejay Diagnostics, Inc. (BJDX) Company Bio
Bluejay Diagnostics, Inc., an in-vitro diagnostic company, develops, manufactures, and markets minimally invasive point-of-care (POC) diagnostics tests and devices for infectious disease, inflammation, and oncology markets in the United States. It is developing Symphony biomarker detection platform for the detection of sepsis, cancer, cardiac ishcemia, and congestive heart failure. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. It has a collaboration agreement with Toray Industries, Inc. to develop a point of care test for covid-19 patient triage; and a research and development agreement with Naval Medical Research Center to develop lateral flow rapid test for diagnosis of various tick-borne diseases, including Lyme disease. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
BJDX Price Returns
| 1-mo | 0.00% |
| 3-mo | -24.89% |
| 6-mo | -53.24% |
| 1-year | -94.21% |
| 3-year | -99.98% |
| 5-year | N/A |
| YTD | -65.91% |
| 2024 | -99.00% |
| 2023 | -83.94% |
| 2022 | -85.16% |
| 2021 | N/A |
| 2020 | N/A |
Loading social stream, please wait...